Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN
Overview
Authors
Affiliations
Background And Objectives: Our study explored the association of histopathologic classification of ANCA-associated GN with renal survival in Chinese patients with myeloperoxidase-ANCA-associated GN.
Design, Setting, Participants, & Measurements: Two hundred fifteen patients with biopsy-proven myeloperoxidase-ANCA-associated GN were included from January of 1996 to December of 2014. The biopsies included focal (=27), mixed (=82), crescentic (=47), and sclerotic (=59) classes. The long-term renal outcome and risk factors of myeloperoxidase-ANCA-associated GN for different histopathologic classes were retrospectively analyzed.
Results: During a median follow-up time of 22 (9-51) months, 88 (40.9%) patients reached ESRD. The 5-year renal survival (overall 58.7%) was highest in the focal class (100.0%) and lowest in the sclerotic class (20.7%), with no difference between the mixed (58.9%) and crescentic (67.4%) classes. Patients in the mixed (hazard ratio, 0.34; 95% confidence interval, 0.20 to 0.57; <0.001) and crescentic (hazard ratio, 0.31; 95% confidence interval, 0.16 to 0.59; <0.001) classes were at lower risk for ESRD compared with patients in the sclerotic class, as were patients who received glucocorticoids plus mycophenolate mofetil (hazard ratio, 0.32; 95% confidence interval, 0.18 to 0.60; <0.001) compared with those receiving glucocorticoids alone. In addition, patients with a serum creatinine level ≥4 mg/dl (hazard ratio, 2.93; 95% confidence interval, 1.77 to 4.85; <0.001) or hypoalbuminemia (hazard ratio, 2.11; 95% confidence interval, 1.32 to 3.34; =0.002) were at higher risk for ESRD. A serum creatinine level ≥4 mg/dl and a percentage of global sclerotic glomeruli ≥60% were the two independent risk factors for ESRD in the sclerotic class.
Conclusions: The histopathologic classification of ANCA-associated GN in combination with serum creatinine and serum albumin levels and treatment regimen is associated with renal outcome in myeloperoxidase-ANCA-associated GN. The evaluation of serum creatinine level and percentage of global sclerotic glomeruli provides additional information on the risk of renal survival in the sclerotic class of myeloperoxidase-ANCA-associated GN.
Ni A, Xu Y, Chen J, Han F J Inflamm Res. 2025; 17():11881-11900.
PMID: 39802155 PMC: 11725264. DOI: 10.2147/JIR.S494848.
Yang M, Liu X, Chen Y, Chen X, Xu F, Liu Z J Nephrol. 2024; 38(1):215-224.
PMID: 39576457 DOI: 10.1007/s40620-024-02134-z.
Chen S, Li Z, Zhao M, Chen M Kidney Dis (Basel). 2024; 10(5):407-420.
PMID: 39430288 PMC: 11488837. DOI: 10.1159/000540514.
Jin Y, Wang F, Tang J, Luo L, Huang L, Zhou F Clin Exp Med. 2024; 24(1):70.
PMID: 38578316 PMC: 10997538. DOI: 10.1007/s10238-024-01333-z.
Gong Y, Shen C, Meng T, Lin W, Hu X, Tang R Clin Exp Med. 2024; 24(1):66.
PMID: 38564029 PMC: 10987344. DOI: 10.1007/s10238-024-01318-y.